Multimodal imaging of the tumor microenvironment and biological responses to immune therapy

[1]  M. Kiehl,et al.  New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management , 2017, Critical Care.

[2]  M. Suarez‐Almazor,et al.  Adverse Events in Cancer Immunotherapy. , 2017, Advances in experimental medicine and biology.

[3]  M. Kiechle,et al.  CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer , 2016, British Journal of Cancer.

[4]  M. Misra,et al.  Is Interleukin 10 (IL10) Expression in Breast Cancer a Marker of Poor Prognosis? , 2016, Indian Journal of Surgical Oncology.

[5]  Zbigniew Starosolski,et al.  Ultra High-Resolution In vivo Computed Tomography Imaging of Mouse Cerebrovasculature Using a Long Circulating Blood Pool Contrast Agent , 2015, Scientific Reports.

[6]  Marek Ancukiewicz,et al.  Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer , 2015, Proceedings of the National Academy of Sciences.

[7]  Charles M Perou,et al.  Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models , 2014, Clinical Cancer Research.

[8]  S. Grupp,et al.  Current concepts in the diagnosis and management of cytokine release syndrome. , 2014, Blood.

[9]  Wei Huang,et al.  Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer? , 2014, NMR in biomedicine.

[10]  P. Palczewski,et al.  Differentiation of Ovarian Cancers From Borderline Ovarian Tumors on the Basis of Evaluation of Tumor Vascularity in Multi–Row Detector Computed Tomography—Comparison With Histopathology , 2013, International Journal of Gynecologic Cancer.

[11]  Michael C. Schmid,et al.  Impact of tumour associated macrophages in pancreatic cancer , 2013, BMB reports.

[12]  Qiang Hu,et al.  Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism , 2011, PloS one.

[13]  H Rieger,et al.  Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumor. , 2008, Journal of theoretical biology.

[14]  L. Munn,et al.  Aberrant vascular architecture in tumors and its importance in drug-based therapies. , 2003, Drug discovery today.

[15]  R. Jain.  Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. , 2002, Seminars in oncology.

[16]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.